Your browser doesn't support javascript.
loading
Optimisation of b-values for the accurate estimation of the apparent diffusion coefficient (ADC) in whole-body diffusion-weighted MRI in patients with metastatic melanoma.
Knill, Annemarie K; Blackledge, Matthew D; Curcean, Andra; Larkin, James; Turajlic, Samra; Riddell, Angela; Koh, Dow Mu; Messiou, Christina; Winfield, Jessica M.
Afiliação
  • Knill AK; The Institute of Cancer Research, London, UK.
  • Blackledge MD; The Royal Marsden NHS Foundation Trust, London, UK.
  • Curcean A; The Institute of Cancer Research, London, UK.
  • Larkin J; The Institute of Cancer Research, London, UK.
  • Turajlic S; The Royal Marsden NHS Foundation Trust, London, UK.
  • Riddell A; The Royal Marsden NHS Foundation Trust, London, UK.
  • Koh DM; The Royal Marsden NHS Foundation Trust, London, UK.
  • Messiou C; The Francis Crick Institute, London, UK.
  • Winfield JM; The Royal Marsden NHS Foundation Trust, London, UK.
Eur Radiol ; 33(2): 863-871, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36169688
ABSTRACT

OBJECTIVE:

To establish optimised diffusion weightings ('b-values') for acquisition of whole-body diffusion-weighted MRI (WB-DWI) for estimation of the apparent diffusion coefficient (ADC) in patients with metastatic melanoma (MM). Existing recommendations for WB-DWI have not been optimised for the tumour properties in MM; therefore, evaluation of acquisition parameters is essential before embarking on larger studies.

METHODS:

Retrospective clinical data and phantom experiments were used. Clinical data comprised 125 lesions from 14 examinations in 11 patients with multifocal MM, imaged before and/or after treatment with immunotherapy at a single institution. ADC estimates from these data were applied to a model to estimate the optimum b-value. A large non-diffusing phantom was used to assess eddy current-induced geometric distortion.

RESULTS:

Considering all tumour sites from pre- and post-treatment examinations together, metastases exhibited a large range of mean ADC values, [0.67-1.49] × 10-3 mm2/s, and the optimum high b-value (bhigh) for ADC estimation was 1100 (10th-90th percentile 740-1790) s/mm2. At higher b-values, geometric distortion increased, and longer echo times were required, leading to reduced signal.

CONCLUSIONS:

Theoretical optimisation gave an optimum bhigh of 1100 (10th-90th percentile 740-1790) s/mm2 for ADC estimation in MM, with the large range of optimum b-values reflecting the wide range of ADC values in these tumours. Geometric distortion and minimum echo time increase at higher b-values and are not included in the theoretical optimisation; bhigh in the range 750-1100 s/mm2 should be adopted to maintain acceptable image quality but performance should be evaluated for a specific scanner. KEY POINTS • Theoretical optimisation gave an optimum high b-value of 1100 (10th-90th percentile 740-1790) s/mm2 for ADC estimation in metastatic melanoma. • Considering geometric distortion and minimum echo time (TE), a b-value in the range 750-1100 s/mm2 is recommended. • Sites should evaluate the performance of specific scanners to assess the effect of geometric distortion and minimum TE.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Melanoma Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Eur Radiol Assunto da revista: RADIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Melanoma Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Eur Radiol Assunto da revista: RADIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido